Skip to main content
Premium Trial:

Request an Annual Quote

GenoSpace Joins Thomson Reuters' Life Sciences Partner Program

NEW YORK (GenomeWeb News) – Thomson Reuters today said that Cambridge, Mass.-based GenoSpace has joined its Life Sciences Partner Ecosystem and will work with the company to develop an integrated product offering for analyzing and interpreting human genomic variation.

Specifically, Thomson Reuters said that it will work with GenoSpace to annotate and publish a gene variant database, with an emphasis on medical and scientific utility. The platform will provide access to curated, medically relevant information, which will include pathway and disease biology as well as regulatory and financial information.

Joseph Donahue, senior vice president at Thomson Reuters, said the company expects through this partnership to provide "large-scale clinical genomic datasets and tools to help in annotating and interpreting genomic variation and support better informed medical treatment decisions." Customers will include hospitals, health systems, disease foundations, and pharmaceutical research organizations, he said.

GenoSpace CEO John Quackenbush added that by pairing his firm's ability to "synthesize" genomic and clinical data with the Thomson Reuters' information resources, "we are positioned to lead the implementation of personalized medicine."

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.